Preoperative Pain Threshold and Rapid Recover Programs

April 4, 2019 updated by: Duke University

Preoperative Pain Threshold and Rapid Recover Programs in Total Joint Arthroplasty

To investigate the association between grip strength and preoperative pain threshold as measured by pressure algometer and validated pain outcome surveys.

Study Overview

Status

Completed

Detailed Description

A minimum of 200 patients, 100 hip and 100 knee arthroplasty participants, will be recruited for this study. Preoperatively, patient pain threshold will be recorded both objectively (Pressure algometer) and subjectively (brief pain inventory). In terms of location, objectively this will be tested during the preoperative visit in clinic by the approved, trained research staff, as well as the subjective brief pain inventory.

Objective pain measure: Pressure algometer will be obtained in the standard fashion as follows: the probe is applied at a 90 degree angle to the skin at a constant rate of 10kPa/s to minimize the impact of the examiner's reaction time on recorded pain thresholds. The participant is instructed by the measurer to say "stop" when the sensation of pressure became the very first sensation of pain. There will be three spots to test patients, one for familiarity of the testing and the other 2 for data collection.

  1. This is initially performed once on ipsilateral the tibialis anterior as a "warm up."
  2. Then 3 measurements are taken on the operative medial epicondyle (for TKA) or ipsilateral lateral iliac crest (for THA) and averaged for the official score.
  3. Lastly, three measurements are also taken on the contralateral olecranon to measure systemic pain sensitivity. If the contralateral elbow has had prior surgery or active bursitis, the ipsilateral elbow will be used. Of important note, the algometer has a max force lock out of 100N to prevent any harm to the patient.
  4. Dominant Hand Grip strength measured by the average of 3 attempts on a Dynamometer.

Subjectively, the brief pain inventory is a validated pain outcome measure which will be filled out by the participant during their preoperative clinic visit.

Postoperative, the study team will ask the participant at the 6 week mark:

  1. How many and what kind of opiates did the participant require?
  2. How many days did the participant require opiates?
  3. Did the participant require a refill? a. If so, did the participant have this filled in clinic preemptively or place a phone call to the office?

Study Type

Interventional

Enrollment (Actual)

201

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27703
        • Duke Medical Plaza Page Road

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • any participant undergoing elective primary total knee arthroplasty or total hip arthroplasty
  • Participants of the following investigators will be approached: Bolognesi, Wellman, Attarian, and Seyler

Exclusion Criteria:

  • previous hip or knee surgery in the operative joint

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inpatient length of stay in days
Time Frame: 1-3 on days average
amount of time in hospital
1-3 on days average
pain control average visual analogue scale 1 - 10 of hospital stay
Time Frame: 1-3 days on average
averaging the subjective pain control
1-3 days on average
physical therapy performance on the first day after surgery
Time Frame: post op day 1
distance walked in feet on post op day 1
post op day 1
discharge location placement
Time Frame: 1 - 3 days on average
home, rehab or nursing facility
1 - 3 days on average

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outpatient narcotic pill consumption
Time Frame: 6-week from surgery
narcotic equivalents consumed by patient in morphine equivalents. we will convert all medicine to the standard unit
6-week from surgery
Outpatient narcotic consumption refill needed
Time Frame: 6-week from surgery
need for refill prescription, yes or no
6-week from surgery
Outpatient narcotic consumption multiple refills needed
Time Frame: 6-week from surgery
number of refills needed requiring provider time outside of scheduled appointment
6-week from surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications short term after surgery
Time Frame: 6-week from surgery
Inpatient complications while in the hospital
6-week from surgery
Complications long term after surgery
Time Frame: surgery to 1yr postoperative
Outpatient complications seen after discharge
surgery to 1yr postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

August 6, 2018

Study Registration Dates

First Submitted

March 16, 2016

First Submitted That Met QC Criteria

April 13, 2016

First Posted (Estimate)

April 15, 2016

Study Record Updates

Last Update Posted (Actual)

April 8, 2019

Last Update Submitted That Met QC Criteria

April 4, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00069521

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthritis

Clinical Trials on Wagner Pain Algometer

Subscribe